A Phase 1 Open Label, Single Arm Trial To Evaluate The Effect Of Pf-00299804 On The Pharmacokinetics Of Dextromethorphan In Patients With Advanced Malignant Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Dacomitinib (Primary) ; Dextromethorphan
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Pfizer
- 01 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2013 Planned end date changed from 1 May 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 16 Mar 2012 Planned end date changed from 1 Mar 2012 to 1 May 2013 as reported by ClinicalTrials.gov.